This inventor holds 1 USPTO granted patent. Top assignee: Tasly Pharmaceutical Group Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Tiantian Wen and Pharmaceutical Innovation for Myocardial Ischemia.
Introduction
Tiantian Wen is an inventor based in Tianjin, China, whose patent work includes a pharmaceutical composition intended to prevent or treat myocardial ischemia. The supplied information identifies her as a woman and lists Tasly Pharmaceutical Group Co., Ltd. as her company.
Latest Patents
Wen is associated with 1 patent: “Pharmaceutical Composition for Treating Myocardial Ischemia and Preparation Method Therefor.” The invention describes a composition containing 250–700 parts by weight of Salvia miltiorrhiza medicinal material, 50–150 parts of Radix notoginseng medicinal material, 3–9 parts of synthetic borneol, and 25–100 parts of ranolazine. It also describes using the composition to prepare a medicine for the prevention or treatment of myocardial ischemia.
Career Highlights
The listed patent reflects work on combining traditional medicinal materials with ranolazine in a formulation directed at myocardial ischemia. The supplied information associates Wen’s work with Tasly Pharmaceutical Group Co., Ltd.
Collaborations
The listed coworkers are He Sun and Kaijing Yan. The supplied information does not specify their roles or the nature of their collaboration with Wen.
Conclusion
Tiantian Wen’s listed patent focuses on a pharmaceutical composition and its potential use in preventing or treating myocardial ischemia, highlighting her contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile